Youcare Pharmaceutical Group Co. Ltd. Class ASSE: 688658

"Youcare Pharmaceutical Group Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval from NMPA for New Indication of Subsidiary's YKYY033 Injection

Jul 22, 2026 · Issued by Youcare Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval from NMPA for New Indication of Subsidiary's YKYY033 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Youcare Pharmaceutical Group Co. Ltd. Class A

Announcement on Voluntary Disclosure of YKYY017 Aerosol Inhalation Formulation Receiving FDA Clinical Trial Approval for the Indication of Prophylaxis and Treatment of Coronavirus-Associated Respiratory InfectionsJun 27
Announcement on Voluntary Disclosure of Withdrawal of Drug Registration Application by a SubsidiaryJun 18
Announcement on Unfreezing of Partial Shares Held by Controlling ShareholdersJun 12
Announcement on Completing the Transfer Registration in Judicial Auction of Partial Shares Held by Controlling ShareholdersMay 28

All Youcare Pharmaceutical Group Co. Ltd. Class A news releases